No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr9:72435400-72437400 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|
2 |
chr9:72435400-72437800 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
3 |
chr9:72435600-72437400 |
Enhancers |
Fetal Lung |
lung
|
4 |
chr9:72435800-72437600 |
Enhancers |
Cortex derived primary cultured neurospheres |
brain
|
5 |
chr9:72435800-72437800 |
Active TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
6 |
chr9:72436000-72437200 |
Weak transcription |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
7 |
chr9:72436000-72437200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
8 |
chr9:72436000-72437600 |
Enhancers |
NHDF-Ad |
bronchial
|
9 |
chr9:72436000-72438000 |
Enhancers |
Primary T cells from cord blood |
blood
|
10 |
chr9:72436000-72438400 |
Weak transcription |
K562 |
blood
|
11 |
chr9:72436200-72437800 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
12 |
chr9:72436200-72438000 |
Enhancers |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
13 |
chr9:72436200-72440800 |
Weak transcription |
Primary T helper naive cells fromperipheralblood |
blood
|
14 |
chr9:72436200-72441200 |
Weak transcription |
Primary T helper cells PMA-I stimulated |
--
|
15 |
chr9:72436400-72437400 |
Flanking Active TSS |
HUES64 Cell Line |
embryonic stem cell
|
16 |
chr9:72436400-72437400 |
Weak transcription |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
17 |
chr9:72436400-72437400 |
Enhancers |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
18 |
chr9:72436400-72437800 |
Enhancers |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
19 |
chr9:72436400-72437800 |
Flanking Active TSS |
HUES48 Cell Line |
embryonic stem cell
|
20 |
chr9:72436400-72438000 |
Flanking Active TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
21 |
chr9:72436400-72438400 |
Flanking Active TSS |
iPS-20b Cell Line |
embryonic stem cell
|
22 |
chr9:72436400-72438600 |
Enhancers |
H9 Cell Line |
embryonic stem cell
|
23 |
chr9:72436400-72439400 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
24 |
chr9:72436600-72437800 |
Enhancers |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
25 |
chr9:72436600-72439400 |
Enhancers |
H1 Cell Line |
embryonic stem cell
|
26 |
chr9:72436600-72442400 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
27 |
chr9:72436800-72437200 |
Active TSS |
iPS-15b Cell Line |
embryonic stem cell
|
28 |
chr9:72436800-72437400 |
Flanking Active TSS |
iPS-18 Cell Line |
embryonic stem cell
|
29 |
chr9:72436800-72437400 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
30 |
chr9:72436800-72437600 |
Flanking Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
31 |
chr9:72436800-72437800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
32 |
chr9:72437000-72437400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
33 |
chr9:72437000-72437400 |
Enhancers |
Osteobl |
bone
|
34 |
chr9:72437000-72437800 |
Flanking Active TSS |
ES-I3 Cell Line |
embryonic stem cell
|
35 |
chr9:72437000-72437800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|